Physician profile
John Bedeau
NPI 1487646154
$3,496.61
in general payments reported to CMS, 2019-2025
36 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $304 · 2021: $435 · 2022: $407 · 2023: $500 · 2024: $473 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $666.06 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Merck Sharp & Dohme LLC | $472.29 | 2019-2025 | Verquvo, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $320.54 | 2019-2025 | Eliquis, Camzyos |
| Abbvie INC. | $224.35 | 2021-2025 | Linzess, Viberzi |
| Bayer Healthcare Pharmaceuticals INC. | $174.70 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $156.48 | 2019 | |
| Alnylam Pharmaceuticals INC. | $138.38 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $125.20 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $108.61 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $98.58 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.88 | 2019-2023 | Jardiance |
| Ironwood Pharmaceuticals, INC | $84.71 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $76.79 | 2023 | Edarbi |
| Boston Scientific Corporation | $73.45 | 2019 | |
| Amarin Pharma, INC. | $59.89 | 2022-2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $55.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.53 | 2021-2022 | |
| Janssen Biotech, INC. | $48.52 | 2022-2024 | Stelara |
| Novartis Pharmaceuticals Corporation | $46.86 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $41.87 | 2019-2024 | |
| Corcept Therapeutics | $41.35 | 2024 | Korlym |
| Atricure, INC. | $40.19 | 2022 | |
| Ferring Pharmaceuticals INC. | $30.80 | 2019 | |
| Ardelyx, INC. | $30.31 | 2024 | Ibsrela |
| Fujifilm New Development USA, INC. | $27.49 | 2019 | |
| Intercept Pharmaceuticals, INC. | $25.15 | 2019 | |
| Genzyme Corporation | $25.00 | 2025 | |
| Abbott Laboratories | $23.72 | 2021 | |
| Heartflow, INC. | $20.43 | 2024 | |
| Lilly USA, LLC | $20.03 | 2021 | |
| Braintree Laboratories, INC. | $19.80 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.88 | 2021 | |
| Glaxosmithkline, LLC. | $16.98 | 2019 | |
| Allergan, INC. | $14.88 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.46 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bedeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.